[Whitepaper] Cortellis Q2 2019 M&A report

As part of its ongoing coverage of mergers and acquisitions (M&A) activity in the life sciences sector, Cortellis Deals Intelligence registered 136 new M&As. Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends. Understand why disclosed biopharma M&A value was $105.3 billion in the second quarter of 2019 which is a 7% decline from $113.7 billion in the second quarter of 2018.

Sponsored by: